Overview
Congenital aortopulmonary window (also known as aortopulmonary septal defect, aortopulmonary fenestration, or aorticopulmonary window) is a rare congenital heart defect characterized by an abnormal communication (opening) between the ascending aorta and the pulmonary artery in the presence of two separate semilunar valves. This distinguishes it from truncus arteriosus, where there is a single outflow valve. The defect allows oxygenated blood from the aorta to shunt into the pulmonary artery (left-to-right shunt), leading to excessive blood flow to the lungs and volume overload of the left heart chambers. Clinical presentation typically occurs in the neonatal or early infantile period. Affected infants may develop signs of congestive heart failure, including tachypnea (rapid breathing), poor feeding, failure to thrive, recurrent respiratory infections, and a continuous or systolic heart murmur. If left untreated, the persistent high-pressure left-to-right shunt can lead to irreversible pulmonary vascular disease (Eisenmenger syndrome), which carries a very poor prognosis. Associated cardiac anomalies are found in approximately 50% of cases and may include interrupted aortic arch, tetralogy of Fallot, ventricular septal defect, patent ductus arteriosus, and anomalous origin of a coronary artery. Diagnosis is established through echocardiography, often supplemented by cardiac catheterization or CT/MRI angiography. The standard treatment is early surgical repair, ideally performed in infancy before pulmonary vascular disease develops. Surgical closure—either by direct patch closure or division of the communication—has excellent outcomes when performed early, with low operative mortality and good long-term survival. Without surgical intervention, mortality in infancy and early childhood is high. Long-term follow-up after repair is recommended to monitor for residual defects, pulmonary artery stenosis, or aortic regurgitation.
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital aortopulmonary window.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital aortopulmonary window at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital aortopulmonary window.
Community
No community posts yet. Be the first to share your experience with Congenital aortopulmonary window.
Start the conversation →Latest news about Congenital aortopulmonary window
No recent news articles for Congenital aortopulmonary window.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital aortopulmonary window
What is Congenital aortopulmonary window?
Congenital aortopulmonary window (also known as aortopulmonary septal defect, aortopulmonary fenestration, or aorticopulmonary window) is a rare congenital heart defect characterized by an abnormal communication (opening) between the ascending aorta and the pulmonary artery in the presence of two separate semilunar valves. This distinguishes it from truncus arteriosus, where there is a single outflow valve. The defect allows oxygenated blood from the aorta to shunt into the pulmonary artery (left-to-right shunt), leading to excessive blood flow to the lungs and volume overload of the left hear
How is Congenital aortopulmonary window inherited?
Congenital aortopulmonary window follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital aortopulmonary window typically begin?
Typical onset of Congenital aortopulmonary window is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital aortopulmonary window?
7 specialists and care centers treating Congenital aortopulmonary window are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.